JP2024525665A5 - - Google Patents
Info
- Publication number
- JP2024525665A5 JP2024525665A5 JP2024501179A JP2024501179A JP2024525665A5 JP 2024525665 A5 JP2024525665 A5 JP 2024525665A5 JP 2024501179 A JP2024501179 A JP 2024501179A JP 2024501179 A JP2024501179 A JP 2024501179A JP 2024525665 A5 JP2024525665 A5 JP 2024525665A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- prime
- polynucleotide
- composition according
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163218744P | 2021-07-06 | 2021-07-06 | |
| US63/218,744 | 2021-07-06 | ||
| US202163219623P | 2021-07-08 | 2021-07-08 | |
| US63/219,623 | 2021-07-08 | ||
| PCT/US2022/035613 WO2023283092A1 (en) | 2021-07-06 | 2022-06-29 | Compositions and methods for efficient genome editing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525665A JP2024525665A (ja) | 2024-07-12 |
| JP2024525665A5 true JP2024525665A5 (enExample) | 2025-07-07 |
Family
ID=84800962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501179A Pending JP2024525665A (ja) | 2021-07-06 | 2022-06-29 | 効率的なゲノム編集のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240228988A1 (enExample) |
| EP (1) | EP4367227A4 (enExample) |
| JP (1) | JP2024525665A (enExample) |
| AU (1) | AU2022306377A1 (enExample) |
| CA (1) | CA3224970A1 (enExample) |
| WO (1) | WO2023283092A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020191233A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| KR20230053735A (ko) | 2020-03-04 | 2023-04-21 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 게놈의 조정을 위한 개선된 방법 및 조성물 |
| IL297761A (en) | 2020-05-08 | 2022-12-01 | Broad Inst Inc | Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence |
| CA3231712A1 (en) | 2021-09-08 | 2023-03-16 | Flagship Pioneering Innovations Vi, Llc | Pah-modulating compositions and methods |
| AU2022343268A1 (en) | 2021-09-08 | 2024-03-28 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
| JP2024534945A (ja) * | 2021-09-10 | 2024-09-26 | アジレント・テクノロジーズ・インク | 化学修飾を有するプライム編集のためのガイドｒｎａ |
| WO2023108153A2 (en) | 2021-12-10 | 2023-06-15 | Flagship Pioneering Innovations Vi, Llc | Cftr-modulating compositions and methods |
| WO2023225670A2 (en) | 2022-05-20 | 2023-11-23 | Tome Biosciences, Inc. | Ex vivo programmable gene insertion |
| WO2024020587A2 (en) | 2022-07-22 | 2024-01-25 | Tome Biosciences, Inc. | Pleiopluripotent stem cell programmable gene insertion |
| EP4665865A1 (en) | 2023-02-17 | 2025-12-24 | Anjarium Biosciences AG | Methods of making dna molecules and compositions and uses thereof |
| WO2024178144A1 (en) * | 2023-02-22 | 2024-08-29 | Prime Medicine, Inc. | Methods and compositions for editing nucleotide sequences |
| EP4720304A2 (en) * | 2023-05-31 | 2026-04-08 | University of Massachusetts | Improved modular prime editing with modified effectors and templates |
| WO2024259051A1 (en) * | 2023-06-14 | 2024-12-19 | The Children's Medical Center Corporation | Systems and methods for modifying a polynucleotide |
| WO2025038881A1 (en) * | 2023-08-16 | 2025-02-20 | Beam Therapeutics Inc. | Prime editing of single base mutations in sickle cell disease |
| WO2025076306A1 (en) * | 2023-10-06 | 2025-04-10 | University Of Massachusetts | Prime editors having improved prime editing efficiency |
| US20250354138A1 (en) | 2024-03-15 | 2025-11-20 | Beam Therapeutics Inc. | Prime editing of single base mutations in alpha-1 antitrypsin deficiency |
| WO2025226946A1 (en) * | 2024-04-24 | 2025-10-30 | Cedric Francois | Methods and compositions for the treatment of androgenic alopecia |
| WO2025231071A1 (en) * | 2024-05-01 | 2025-11-06 | Beam Therapeutics Inc. | Compositions and methods for cell conditioning |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3775239A4 (en) * | 2018-03-25 | 2022-01-05 | Genetether, Inc | MODIFIED NUCLEIC ACID EDITING SYSTEM FOR BINDING DONOR DNA |
| US20210355475A1 (en) * | 2018-08-10 | 2021-11-18 | Cornell University | Optimized base editors enable efficient editing in cells, organoids and mice |
| AU2020215730A1 (en) * | 2019-01-31 | 2021-07-29 | Beam Therapeutics Inc. | Nucleobase editors having reduced non-target deamination and assays for characterizing nucleobase editors |
| CN116656676A (zh) * | 2019-02-02 | 2023-08-29 | 上海科技大学 | 一对用于编辑人pcsk9核酸序列的辅助引导rna/引导rna |
| WO2020191233A1 (en) * | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| US20220411777A1 (en) * | 2019-08-30 | 2022-12-29 | The General Hospital Corporation | C-to-G Transversion DNA Base Editors |
| CN114829594B (zh) * | 2019-12-26 | 2025-03-21 | 新加坡科技研究局 | 核碱基编辑器 |
-
2022
- 2022-06-29 WO PCT/US2022/035613 patent/WO2023283092A1/en not_active Ceased
- 2022-06-29 AU AU2022306377A patent/AU2022306377A1/en active Pending
- 2022-06-29 JP JP2024501179A patent/JP2024525665A/ja active Pending
- 2022-06-29 EP EP22838255.2A patent/EP4367227A4/en active Pending
- 2022-06-29 CA CA3224970A patent/CA3224970A1/en active Pending
-
2024
- 2024-01-04 US US18/404,456 patent/US20240228988A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024525665A5 (enExample) | ||
| JP2023553935A5 (enExample) | ||
| AU736707B2 (en) | Trimerising module | |
| JP2024534523A5 (enExample) | ||
| JP2002503459A (ja) | 繊維置換タンパク質を含有する修飾されたアデノウィルス | |
| JP2002503459A5 (enExample) | ||
| JPS62501470A (ja) | 腫瘍壊死因子の精製、製造および使用法 | |
| JP2024533311A5 (enExample) | ||
| JPS60252496A (ja) | 新規なヒト生理活性ポリペプチド | |
| JP2023534924A5 (enExample) | ||
| JP2024511131A5 (enExample) | ||
| JP2024542995A5 (enExample) | ||
| US5854025A (en) | IGF-II analogues | |
| JPH0866194A (ja) | ヒト腫瘍壊死因子ミューテインをコードする遺伝子 | |
| JP7736329B2 (ja) | Ｄｕｘ４遺伝子を標的とした顔面肩甲上腕型筋ジストロフィーの治療方法 | |
| US7981446B2 (en) | Pharmaceutical compositions and methods for delivering nucleic acids into cells | |
| JP2024533314A5 (enExample) | ||
| JP2024528967A5 (enExample) | ||
| JP3455785B2 (ja) | ヒト肝癌細胞由来増殖因子の遺伝子 | |
| JP7341451B2 (ja) | タンパク質性化合物とその利用 | |
| Christie et al. | A functional hybrid ribosome binding site in tryptophan operon messenger RNA of Escherichia coli | |
| EP4520767A1 (en) | Peptide kinase inhibitors and methods of use thereof | |
| JP2946019B2 (ja) | ｈＴＦＩＩＩＡ遺伝子 | |
| JP4805641B2 (ja) | 頭頚部癌抑制剤および医薬組成物 | |
| CN116041472A (zh) | 一种具有高效端粒酶抑制活性的活性片段、融合蛋白及其制备方法和应用 |